ID: ALA4552819

Max Phase: Preclinical

Molecular Formula: C18H25NO3

Molecular Weight: 303.40

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(CCCCCCC(=O)N2CCCC2)cc1

Standard InChI:  InChI=1S/C18H25NO3/c20-17(19-13-5-6-14-19)8-4-2-1-3-7-15-9-11-16(12-10-15)18(21)22/h9-12H,1-8,13-14H2,(H,21,22)

Standard InChI Key:  TZDCXLHGQIPSCY-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.40Molecular Weight (Monoisotopic): 303.1834AlogP: 3.50#Rotatable Bonds: 8
Polar Surface Area: 57.61Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.24CX Basic pKa: CX LogP: 3.54CX LogD: 0.53
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: -0.39

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source